ProCE Banner Activity

Low Weight Gain Over 96 Wks in Treatment-Naive Patients Initiating ART With Doravirine

Slideset Download
Conference Coverage
In patients receiving first-line doravirine, median weight gain over 96 weeks was 1.5 kg, a change similar to that seen in adults without HIV infection and in those starting ART with other agents.

Released: November 18, 2019

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare